Your browser doesn't support javascript.
loading
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer, Julie R; Rodríguez-Abreu, Delvys; Robinson, Andrew G; Hui, Rina; Csoszi, Tibor; Fülöp, Andrea; Gottfried, Maya; Peled, Nir; Tafreshi, Ali; Cuffe, Sinead; O'Brien, Mary; Rao, Suman; Hotta, Katsuyuki; Zhang, Jin; Lubiniecki, Gregory M; Deitz, Anne C; Rangwala, Reshma; Reck, Martin.
Afiliación
  • Brahmer JR; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. Electronic address: brahmju@jhmi.edu.
  • Rodríguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.
  • Robinson AG; Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, Canada.
  • Hui R; Westmead Hospital and the University of Sydney, Sydney, NSW, Australia.
  • Csoszi T; Jász-Nagykun-Szolnok County Hospital, Szolnok, Hungary.
  • Fülöp A; Országos Korányi TBC és Pulmonológiai Intézet, Budapest, Hungary.
  • Gottfried M; Meir Medical Center, Kfar-Saba, Israel.
  • Peled N; Davidoff Cancer Center, Tel Aviv University, Petah Tikva, Israel.
  • Tafreshi A; Southern Medical Day Care Centre, Wollongong, NSW, Australia.
  • Cuffe S; St. James's Hospital and Cancer Trials Ireland (formerly ICORG - All Ireland Cooperative Oncology Research Group), Dublin, Ireland.
  • O'Brien M; The Royal Marsden Hospital, Sutton, Surrey, UK.
  • Rao S; MedStar Franklin Square Hospital, Baltimore, MD, USA.
  • Hotta K; Okayama University Hospital, Okayama, Japan.
  • Zhang J; Merck & Co, Kenilworth, NJ, USA.
  • Lubiniecki GM; Merck & Co, Kenilworth, NJ, USA.
  • Deitz AC; Merck & Co, Kenilworth, NJ, USA.
  • Rangwala R; Merck & Co, Kenilworth, NJ, USA.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Lancet Oncol ; 18(12): 1600-1609, 2017 12.
Article en En | MEDLINE | ID: mdl-29129441
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article